Single-payer pharmacare could reduce patient access to drugs, say insurers

Single-payer pharmacare could reduce patient access to drugs, say insurers
TORONTO — The Canadian Life and Health Insurance Association says millions of people could risk losing access to certain drugs under even the most comprehensive government-run pharmacare plan. The industry association’s comments came in response to an expert panel’s recommendation that Canada should have a single-payer national pharmacare plan to cover every Canadian. The advisory council, tasked by the federal government to... Read More

Canadian edibles, topicals market worth $2.7B; ramp up over 3-5 years: Deloitte

Canadian edibles, topicals market worth $2.7B; ramp up over 3-5 years: Deloitte
TORONTO — The Canadian market for next-generation cannabis products is worth an estimated $2.7 billion annually, with edibles contributing more than half, according to a new report from Deloitte. This spending once the final edible pot regulations roll out in the coming months is expected to be on top of the roughly $6-billion estimated domestic market for recreational and medical cannabis, the consultancy said Monday. Consumers are looking... Read More

CBD-Infused Beverages Achieve Quality and Clarity Breakthrough Utilizing Pressure BioSciences’ Ultra Shear Technology Platform

CBD-Infused Beverages Achieve Quality and Clarity Breakthrough Utilizing Pressure BioSciences’ Ultra Shear Technology Platform
New Video Demonstrates Revolution in Soft Drinks, Sports Drinks, and Beer with Vanishing Water-Soluble CBD Oil for Enhanced Quality and Absorption Pressure BioSciences, Inc. , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries, today released a new, short video demonstrating the ability of... Read More

Bausch Health reports Q1 loss, raises full-year guidance as stock price leaps

Bausch Health reports Q1 loss, raises full-year guidance as stock price leaps
LAVAL, Que. — Bausch Health Companies Inc. raised its guidance after higher sales at its biggest subsidiary mitigated the blow of a US$52-million loss in its first quarter, boosting its share price. The stock closed up $2.88, or 9.16 per cent, at $34.31. Bausch & Lomb, a segment that generates more than half of the drug company’s revenue, saw revenue rise eight... Read More

Pharmaceutical exec guilty of bribing doctors to push opioid

Pharmaceutical exec guilty of bribing doctors to push opioid
BOSTON — A pharmaceutical company founder accused of paying doctors millions in bribes to prescribe a highly addictive fentanyl spray was convicted Thursday in a case that exposed such marketing tactics as using a stripper-turned-sales-rep to give a physician a lap dance. John Kapoor, the 76-year-old former chairman of Insys Therapeutics, was found guilty of racketeering conspiracy after 15 days... Read More

Loblaw Companies raises quarterly dividend, reports Q1 profit down from year ago

Loblaw Companies raises quarterly dividend, reports Q1 profit down from year ago
BRAMPTON, Ont. — Loblaw Companies Ltd. raised its dividend as it reported a first-quarter profit fell compared with a year ago. The grocery and drugstore retailer says it will now pay a quarterly dividend of 31.5 cents per share, up from 29.5 cents per share. The increased payment to shareholders came as Loblaw reported profit attributable to common shareholders of... Read More

CannTrust preliminary estimates shows Q1 net revenue to more than double

CannTrust preliminary estimates shows Q1 net revenue to more than double
VAUGHAN, Ont. — CannTrust Holdings Inc. says the company’s net revenue for its first full quarter after legalization of recreational cannabis will be $17 million, more than double what it was a year earlier. The cannabis producer says it hasn’t finalized its results for the quarter ended March 31 but preliminary estimates show net revenue will be up 116 per cent... Read More

Mainstream retailers embrace marijuana’s less taboo cousin

Mainstream retailers embrace marijuana’s less taboo cousin
NEW YORK — Mainstream retailers are leaping into the world of products like skin creams and oils that tout such benefits as reducing anxiety and helping you sleep. The key ingredient? CBD, or cannabidiol, a compound derived from hemp and marijuana that doesn’t cause a high. Retailers are taking advantage of the booming industry even as its legal status and... Read More

Companies rush to produce pot products, without the cannabis plant itself

Companies rush to produce pot products, without the cannabis plant itself
TORONTO — Canadian companies are racing to get an edge in the new frontier of the cannabis industry — which does not involve the leafy green plant at all. An increasing number of licensed producers and biotechnology firms are moving towards synthetic production of THC and other cannabinoids in a lab, using ingredients such as sugar and yeast, eyeing the... Read More

New wave of telemedicine uses mobile phone video to link patients, doctors

New wave of telemedicine uses mobile phone video to link patients, doctors
Stick out your smartphone and say AHHHHH. Although it’s early days for a new wave of telemedicine, some Canadians can now avoid trips to the doctor’s office by using their mobile phone’s video camera. In March, Telus Health launched a new video link between patients and select doctors in British Columbia, the only province with a billing code to pay... Read More